{{Rsnum
|rsid=1043879
|Gene=C1orf63
|Chromosome=1
|position=25243590
|Orientation=plus
|GMAF=0.1451
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=RSRP1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 54.9 | 36.3 | 8.8
| HCB | 96.4 | 3.6 | 0.0
| JPT | 99.1 | 0.9 | 0.0
| YRI | 98.6 | 1.4 | 0.0
| ASW | 87.7 | 12.3 | 0.0
| CHB | 96.4 | 3.6 | 0.0
| CHD | 95.4 | 4.6 | 0.0
| GIH | 89.1 | 9.9 | 1.0
| LWK | 97.3 | 2.7 | 0.0
| MEX | 69.0 | 27.6 | 3.4
| MKK | 81.4 | 18.6 | 0.0
| TSI | 44.1 | 46.1 | 9.8
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21700265
|Trait=None
|Title=Complement receptor 1 gene variants are associated with erythrocyte sedimentation rate.
|RiskAllele=
|Pval=2E-9
|OR=0.0900
|ORtxt=[NR] unit decrease
|OA=1
}}

{{GET Evidence
|gene=C1ORF63
|aa_change=Glu239Gly
|aa_change_short=E239G
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1043879
|overall_frequency_n=2103
|overall_frequency_d=10758
|overall_frequency=0.195482
|n_genomes=10
|n_genomes_annotated=0
|n_haplomes=12
|n_articles=0
|n_articles_annotated=0
|nblosum100=6
|autoscore=0
|webscore=N
}}

{{PMID Auto
|PMID=23856853
|Title=Association of a complement receptor 1 gene variant with baseline erythrocyte sedimentation rate levels in patients starting anti-TNF therapy in a UK rheumatoid arthritis cohort: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}